A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/1997
11/11/1997	US5686239 Hepatitis E virus peptides and methods
11/11/1997	US5686080 Parasitic helminth p4 proteins
11/11/1997	US5686079 Oral immunization by transgenic plants
11/11/1997	US5686078 Primary and secondary immunization with different physio-chemical forms of antigen
11/11/1997	US5686077 Methods of immunization of poultry with vaccines against chicken anemia agent (CAA)
11/11/1997	US5686076 gD-negative bovine herpesvirus mutant, capable of direct cell-to-cell transmission
11/11/1997	US5686075 Synthetic peptide vaccines for dental caries
11/11/1997	US5686073 Polyclonal and monoclonal antibodies against a 43 KDA dystrophin associated protein
11/11/1997	US5686070 Methods for treating bacterial pneumonia
11/11/1997	US5686068 Isolated peptides derived from MAGE-2, cytolytic T cells specific to complexes of peptide and HLA-A2 molecules, and uses thereof
11/11/1997	CA2134667C In vitro test for helicobacter pylori
11/06/1997	WO1997041440A1 Methods for selecting and producing t cell peptide epitopes and vaccines incorporating said selected epitopes
11/06/1997	WO1997041245A1 Generation of viral transfectants using recombinant dna-derived nucleocapsid proteins
11/06/1997	WO1997041244A1 Vaccines for treatment of lymphoma and leukemia
11/06/1997	WO1997041241A1 Polycistronic expression constructs, their use and vaccines
11/06/1997	WO1997041236A1 Polynucleotide vaccine against canine distemper
11/06/1997	WO1997041227A1 Plasmid-based vaccine for treating atherosclerosis
11/06/1997	WO1997041210A1 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with rna
11/06/1997	WO1997041156A1 Novel compounds
11/06/1997	WO1997041151A2 Choline binding proteins for anti-pneumococcal vaccines
11/06/1997	WO1997041147A1 Novel compounds
11/06/1997	WO1997041146A1 Novel compounds
11/06/1997	WO1997041135A1 Novel compounds
11/06/1997	WO1997040861A1 Biological material free of viral and molecular pathogens and a process for the production thereof
11/06/1997	WO1997040852A1 Improving binding affinity of antigenic peptides for mhc molecules
11/06/1997	WO1997040851A1 Novel compounds
11/06/1997	WO1997040839A1 Dna vaccine formulations
11/06/1997	WO1997040832A1 Use of dipeptidyl peptidase iv effectors for lowering the blood glucose level in mammals
11/06/1997	WO1997032598A3 Vaccines
11/06/1997	DE19705277A1 Formulation for topical treatment of recurrent herpes diseases
11/06/1997	CA2253595A1 Generation of viral transfectants using recombinant dna-derived nucleocapsid proteins
11/06/1997	CA2253300A1 Biological material free of viral and molecular pathogens and a process for the production thereof
11/06/1997	CA2253252A1 Choline binding proteins for anti-pneumococcal vaccines
11/06/1997	CA2253229A1 Polynucleotide vaccine against canine distemper
11/06/1997	CA2252675A1 Methods for selecting and producing t cell peptide epitopes and vaccines incorporating said selected epitopes
11/06/1997	CA2250428A1 Plasmid-based vaccine for treating atherosclerosis
11/06/1997	CA2204565A1 Attenuated strains of leishmania and uses thereof
11/06/1997	CA2203234A1 Feline vaccines containing chlamydia psittaci and method for making the same
11/05/1997	EP0805207A1 Polycistronic expression plasmid for tumor rejection
11/05/1997	EP0805203A1 The use of a substance which prevents HGS/SF from binding with Met
11/05/1997	EP0805162A1 Peptide determinant associated with immunity
11/05/1997	EP0804728A1 Assay, receptor proteins and ligands
11/05/1997	EP0804613A1 Tumor suppressor genes, proteins encoded thereby and use of said genes and proteins
11/05/1997	EP0804602A1 Hsv viral vector
11/05/1997	EP0804601A1 Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle
11/05/1997	EP0804597A1 Activation of t-cells by modified, antigenic immunoglobulins
11/05/1997	EP0804581A1 Compounds and methods for the stimulation and enhancement of protective immune responses and il-12 production
11/05/1997	EP0804580A1 Calcium binding recombinant antibody against protein c
11/05/1997	EP0804572A1 Protein tyrosine kinase agonist antibodies
11/05/1997	EP0804570A1 Vaccines against helminthic parasites
11/05/1997	EP0804552A1 Redirection of cellular immunity by receptor chimeras
11/05/1997	EP0804549A1 Isolated porcine pancreatic cells for use in treatment of diseases characterized by insufficient insulin activity
11/05/1997	EP0804547A1 Unique associated kaposi's sarcoma virus sequences and uses thereof
11/05/1997	EP0804546A1 Human prostatic specific reductase
11/05/1997	EP0804542A1 Methods for producing enhanced antigenic enteric bacteria and vaccines comprising same
11/05/1997	EP0804489A1 Antigenic preparation for treatment or prevention of helicobacter infection
11/05/1997	EP0804487A2 Bispecific antigen-binding molecules
11/05/1997	EP0804484A1 Antigenic polypeptide sequence of factor viii, fragments and/or epitopes thereof
11/05/1997	EP0804483A1 Isolated peptides derived from mage tumor rejection antigen precursors which complex with hla-a2 molecules
11/05/1997	EP0804482A1 Cytokines that bind the cell surface receptor hek
11/05/1997	EP0804475A1 Polypeptides and their use in treatment and prophylaxis of auto-immune disease
11/05/1997	EP0804472A1 Mosaic polypeptide and methods for detecting the hepatitis e virus
11/05/1997	EP0804451A1 Lung cancer marker
11/05/1997	EP0804283A1 Aqueous solvent encapsulation method, apparatus and microcapsules
11/05/1997	EP0804237A1 Humanized antibodies against leukocyte adhesion molecule vla-4
11/05/1997	EP0804236A1 Use of anti-tnf antibodies as drugs in treating diseases involving elevated interleukin-6 serum levels
11/05/1997	EP0804234A1 Vaccine adjuvants
11/05/1997	EP0804233A1 Methods for the cultivation of infectious laryngotracheitis virus and egg drop syndrome virus
11/05/1997	EP0804232A1 Para-influenza virus-containing vaccines for preventing porcine reproductive and respiratory syndrome
11/05/1997	EP0804231A1 Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof
11/05/1997	EP0804230A1 Vaccine against mycobacterial infections
11/05/1997	EP0804222A1 Accessory factor function for interferon gamma and its receptor
11/05/1997	EP0804219A1 Inhibin compositions and methods of use thereof
11/05/1997	EP0804214A1 Growth differentiation factor-6
11/05/1997	EP0804212A2 $i(NIGELLA SATIVA) AS A MEDICINAL TREATMENT
11/05/1997	EP0804164A2 Method of priming an immune response in a one-day old animal
11/05/1997	EP0804158A1 Compositions and methods for eliciting ctl immunity
11/05/1997	EP0804070A1 Isolation of components of interest from milk
11/05/1997	EP0703989B1 COMPOSITIONS AND DIAGNOSTIC METHODS USING MONOCLONAL ANTIBODIES AGAINST CD44v6
11/05/1997	EP0487718B1 NUCLEIC ACID PROBES with negatively charged haptens which are attached to the probe via a hydrazine binding moiety
11/05/1997	EP0432203B1 Legionellosis vaccines and methods for their production
11/05/1997	CN1164258A Nucleotide sequences of HIV-10 type (or subtype) O retrovirus antigens
11/05/1997	CN1164238A Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor
11/05/1997	CN1164194A Remedy for diseases caused by IL-6 production
11/05/1997	CN1164191A Mutant enterotoxin effective as non-toxic oral adjuvant
11/05/1997	CN1163936A Recombination eukaryotic vector containing sensitinogen gene and application thereof
11/04/1997	US5684146 DNA coding for variable region to human influenza A type virus
11/04/1997	US5684145 Carrier system against GNRH
11/04/1997	US5684133 Neurite growth regulatory factors, antibodies thereto, and pharmaceutical compositions
11/04/1997	US5683901 Method of producing RNA viruses from cDNA
11/04/1997	US5683900 Pasteurella haemolytica PhaI restriction endonuclcape and methyltranstesase
11/04/1997	US5683887 Immunochemical detection of in vivo advanced glycosylation endproducts
11/04/1997	US5683865 Method for diagnosis of mystery swine disease
11/04/1997	US5683864 Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
11/04/1997	US5683702 Influenza vaccines
11/04/1997	US5683701 Peptide fragments of HIV
11/04/1997	US5683700 Immunization using an attenuated salmonella bacterium containing an nirb promoter linked to a dna sequence encoding a heterologous protein
11/04/1997	US5683699 Meningococcal polysaccharide conjugate vaccine
11/04/1997	US5683698 Plant extracts
11/04/1997	US5683696 Cloning of duffy blood group antigen, gpD

1 ... 1598 1599 1600 1601 1602 1603 1604 1605 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 ... 1823